Fusion Antibodies plc (AIM: FAB)
London
· Delayed Price · Currency is GBP · Price in GBX 9.40
+0.25 (2.73%)
Jan 22, 2025, 12:14 PM GMT+1
Fusion Antibodies Market Cap
Fusion Antibodies has a market cap or net worth of 8.78 million as of January 22, 2025. Its market cap has increased by 247.47% in one year.
Market Cap
8.78M
Enterprise Value
8.37M
Revenue
1.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.40
Market Cap Chart
Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 8.78M, a decrease of -67.82%. That is a compound annual growth rate of -14.76%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.37B |
| GSK plc | 55.25B |
| Haleon | 33.81B |
| Smith & Nephew | 8.96B |
| ConvaTec Group | 4.94B |
| Hikma Pharmaceuticals | 4.62B |
| HUTCHMED (China) | 1.99B |
| Oxford Nanopore Technologies | 1.42B |